Target intelligence / Profile preview

Microtubule-associated protein 7 domain-containing protein 1 (MAP7D1)

Target
MAP7D1
Molecular classification
Other (Microtubule-associated protein)
01

Overview

Microtubule-associated protein 7 domain-containing protein 1 (MAP7D1) is a structural protein primarily involved in the stabilization and organization of microtubule cytoskeletons within cells[1][3][5]. It localizes to the centrosome and spindle, facilitating microtubule stability and influencing cellular processes such as motility and neurite outgrowth[1][3][5]. MAP7D1 is also important for the maintenance of acetylated microtubules, which are associated with stable cellular structures[1]. It is predominantly expressed in the brain, muscle, and reproductive tissues[2][6]. While not a direct therapeutic target or receptor, genetic disruption of MAP7D1 increases susceptibility to doxorubicin-induced cardiomyopathy and heart failure, making it a potential biomarker for predicting adverse effects in cancer therapy involving anthracyclines[2].

Other names
MAP7D1KIAA1187PARCC1RPRC1PP2464FLJ10350FLJ39022Arginine/proline-rich coiled-coil domain-containing protein 1Proline/arginine-rich coiled-coil domain-containing protein 1MAP7 domain-containing protein 1arginine/proline rich coiled-coil 1proline arginine rich coiled coil 1
02

Biological functions

Microtubule cytoskeleton organizationMicrotubule stabilizationRegulation of cell motilityRegulation of neurite outgrowthMaintenance of acetylated stable microtubules
03

Disease associations

Cardiovascular disease (Doxorubicin-induced cardiomyopathy and heart failure)Other (Potential implication in diseases affecting cellular structure or motility)
04

Safety considerations

Genetic variation may confer increased risk of anthracycline-induced (doxorubicin) cardiotoxicity[2]
05

Interacting drugs

Doxorubicin (genetic variants influence risk of doxorubicin-induced cardiomyopathy)[2]
06

Biomarkers

MAP7D1 gene variants (for susceptibility to doxorubicin-induced cardiomyopathy)[2]

Beyond the preview

Go deeper on Microtubule-associated protein 7 domain-containing protein 1 (MAP7D1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microtubule-associated protein 7 domain-containing protein 1 (MAP7D1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call